CVE-2024-41668 cBioPortal Proxy Endpoint Vulnerabliity
Attackers can exploit an unauthenticated proxy endpoint to perform Server Side Request Forgery, potentially accessing internal resources or bypassing network restrictions.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2024-41668?
CVE-2024-41668 is a high-severity server-side request forgery vulnerability in cbioportal, published on 23 Jul 2024. An attacker can exploit it over the internet without logging in, with no action from the victim.
Official description
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.
Weakness: CWE-918
Which versions are affected by CVE-2024-41668?
How do I fix CVE-2024-41668?
No fix has been published for CVE-2024-41668 yet. Limit exposure of the affected software until one is available.
Upgrade, and send outbound requests through an allow-list that blocks internal addresses. More about Server-side request forgery.
Is CVE-2024-41668 being exploited?
It is not confirmed as exploited in the wild, but public exploit code for CVE-2024-41668 exists.
Sources
Also known as GHSA-9h44-r3c3-q7rm.